Tenecteplase
Roche Halts Development of Tenecteplase for Stroke
SG Tylor
Roche announced today that it has discontinued the development of its thrombolytic drug tenecteplase for acute ischemic stroke due to ...
Roche announced today that it has discontinued the development of its thrombolytic drug tenecteplase for acute ischemic stroke due to ...